Steven Cohen's IRD Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 18,922 shares of Opus Genetics, Inc. (IRD) worth $77,769, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in IRD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Opus Genetics (IRD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Opus Genetics (IRD) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +18,922 | New Buy | 18,922 | $4.11 |
Steven Cohen's Opus Genetics Investment FAQs
Steven Cohen first purchased Opus Genetics, Inc. (IRD) in Q2 2026, acquiring 18,922 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Opus Genetics, Inc. (IRD) for 1 quarters since Q2 2026.
Steven Cohen's largest addition to Opus Genetics, Inc. (IRD) was in Q2 2026, adding 18,922 shares worth $77,769.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 18,922 shares of Opus Genetics, Inc. (IRD), valued at approximately $77,769.
As of the Q2 2026 filing, Opus Genetics, Inc. (IRD) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Opus Genetics, Inc. (IRD) was 18,922 shares, as reported at the end of Q2 2026.